RxDoctor Payments Data

Lori Williams, PA

Physician Assistant · Manteno, ILNPI 1881762540

Payments from drug & device makers

$11,173in general payments, 2019–2025

Across 534 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Novo Nordisk$2K
  • Boehringer Ingelheim$892
  • Lilly USA, LLC$686
  • Bayer$466
  • plus $4K from 34 others

What the payments were for

  • Food & beverage$11,124100%
  • Education$490%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,173 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$114,661
Medicare patients
301
Services billed
1,405

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide106$137,571
JardianceEmpagliflozin90$104,804
MounjaroTirzepatide46$74,549
TrulicityDulaglutide45$55,387
FarxigaDapagliflozin Propanediol31$41,406
Tresiba Flextouch U-200Insulin Degludec44$38,959
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$24,288
MyrbetriqMirabegron21$22,545
EliquisApixaban20$16,043
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$10,458
Aripiprazole15$6,679
SynjardyEmpagliflozin/Metformin Hcl12$6,558
BelsomraSuvorexant12$6,402
TrintellixVortioxetine Hydrobromide12$6,077
Pantoprazole Sodium192$3,845

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,551$137,571106 claims
Lilly USA, LLCMounjaro, Trulicity$686$129,93691 claims
Boehringer IngelheimJardiance, Synjardy$892$111,362102 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,594$51,86346 claims
GSKTrelegy Ellipta$257$24,28825 claims
Astellas Pharma US IncMyrbetriq$50$22,54521 claims
PfizerEliquis$281$16,04320 claims
MerckBelsomra$223$6,40212 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$129$6,07712 claims
AbbVieSynthroid$1,671$1,71525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Manteno

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →